166 related articles for article (PubMed ID: 36911590)
1. Pediatric Non-Down Syndrome Acute Megakaryoblastic Leukemia With Unusual Immunophenotype.
Koulmane Laxminarayana SL; Kohli S; Agrohi J; Belurkar S
Cureus; 2023 Mar; 15(3):e35965. PubMed ID: 36911590
[TBL] [Abstract][Full Text] [Related]
2. Acute megakaryoblastic leukemia associated with trisomy 21 demonstrates a distinct immunophenotype.
Wang L; Peters JM; Fuda F; Li L; Karandikar NJ; Koduru P; Wang HY; Chen W
Cytometry B Clin Cytom; 2015; 88(4):244-52. PubMed ID: 25361478
[TBL] [Abstract][Full Text] [Related]
3. Acute Megakaryoblastic Leukemia Associated with Trisomy 21 Demonstrates a Distinct Immunophenotype.
Wang L; Peters JM; Fuda F; Li L; Karandikar NJ; Koduru P; Wang H; Chen W
Cytometry B Clin Cytom; 2014 Oct; ():. PubMed ID: 25302938
[TBL] [Abstract][Full Text] [Related]
4. Immunophenotype of Down syndrome acute myeloid leukemia and transient myeloproliferative disease differs significantly from other diseases with morphologically identical or similar blasts.
Langebrake C; Creutzig U; Reinhardt D
Klin Padiatr; 2005; 217(3):126-34. PubMed ID: 15858703
[TBL] [Abstract][Full Text] [Related]
5. Revealing the intratumoral heterogeneity of non-DS acute megakaryoblastic leukemia in single-cell resolution.
Su N; Li Z; Yang J; Fu Y; Zhu X; Miao H; Yu Y; Jiang W; Le J; Qian X; Wang H; Qian M; Zhai X
Front Oncol; 2022; 12():915833. PubMed ID: 36003795
[TBL] [Abstract][Full Text] [Related]
6. Immunophenotypic Analysis of Acute Megakaryoblastic Leukemia: A EuroFlow Study.
Brouwer N; Matarraz S; Nierkens S; Hofmans M; Nováková M; da Costa ES; Fernandez P; Bras AE; de Mello FV; Mejstrikova E; Philippé J; Grigore GE; Pedreira CE; van Dongen JJM; Orfao A; van der Velden VHJ; On Behalf Of The EuroFlow Consortium
Cancers (Basel); 2022 Mar; 14(6):. PubMed ID: 35326734
[TBL] [Abstract][Full Text] [Related]
7. Advances in molecular characterization of pediatric acute megakaryoblastic leukemia not associated with Down syndrome; impact on therapy development.
Li J; Kalev-Zylinska ML
Front Cell Dev Biol; 2023; 11():1170622. PubMed ID: 37325571
[TBL] [Abstract][Full Text] [Related]
8. CD36 (thrombospondin receptor) expression in childhood acute megakaryoblastic leukemia: in vitro drug sensitivity and outcome.
Savaşan S; Buck S; Raimondi SC; Becton DL; Weinstein H; Chang M; Ravindranath Y
Leuk Lymphoma; 2006 Oct; 47(10):2076-83. PubMed ID: 17071479
[TBL] [Abstract][Full Text] [Related]
9. Analysis 33 patients of non-DS-AMKL with or without acquired trisomy 21 from multiple centers and compared to 118 AML patients.
Zhang W; Dun J; Li H; Liu J; Chen H; Yu H; Xu J; Zhou F; Qiu Y; Hao J; Hu Q; Wu X
Hematology; 2023 Dec; 28(1):2231731. PubMed ID: 37522469
[TBL] [Abstract][Full Text] [Related]
10. Unmanipulated haploidentical hematopoietic stem cell transplantation for pediatric
Huang J; Hu G; Suo P; Bai L; Cheng Y; Wang Y; Zhang X; Liu K; Sun Y; Xu L; Kong J; Yan C; Huang X
Front Oncol; 2023; 13():1116205. PubMed ID: 36874138
[TBL] [Abstract][Full Text] [Related]
11. Integrated differential transcriptome maps of Acute Megakaryoblastic Leukemia (AMKL) in children with or without Down Syndrome (DS).
Pelleri MC; Piovesan A; Caracausi M; Berardi AC; Vitale L; Strippoli P
BMC Med Genomics; 2014 Dec; 7():63. PubMed ID: 25476127
[TBL] [Abstract][Full Text] [Related]
12. Pediatric non-Down syndrome acute megakaryoblastic leukemia is characterized by distinct genomic subsets with varying outcomes.
de Rooij JD; Branstetter C; Ma J; Li Y; Walsh MP; Cheng J; Obulkasim A; Dang J; Easton J; Verboon LJ; Mulder HL; Zimmermann M; Koss C; Gupta P; Edmonson M; Rusch M; Lim JY; Reinhardt K; Pigazzi M; Song G; Yeoh AE; Shih LY; Liang DC; Halene S; Krause DS; Zhang J; Downing JR; Locatelli F; Reinhardt D; van den Heuvel-Eibrink MM; Zwaan CM; Fornerod M; Gruber TA
Nat Genet; 2017 Mar; 49(3):451-456. PubMed ID: 28112737
[TBL] [Abstract][Full Text] [Related]
13. Target cell of leukemic transformation in acute megakaryoblastic leukemia.
Koike T; Urushiyama M; Narita M; Saitoh H; Ishida F; Imashuku S; Morioka Y; Utsumi J; Ishizuka T; Tsuruta T
Am J Hematol; 1990 Aug; 34(4):252-8. PubMed ID: 2164321
[TBL] [Abstract][Full Text] [Related]
14. Acute megakaryoblastic leukaemia (AMKL) in children: a comparison of AMKL with and without Down syndrome.
Hama A; Yagasaki H; Takahashi Y; Nishio N; Muramatsu H; Yoshida N; Tanaka M; Hidaka H; Watanabe N; Yoshimi A; Matsumoto K; Kudo K; Kato K; Horibe K; Kojima S
Br J Haematol; 2008 Mar; 140(5):552-61. PubMed ID: 18275433
[TBL] [Abstract][Full Text] [Related]
15. Acute Megakaryoblastic Leukemia with Trisomy 21 and Tetrasomy 21 Clones in a Phenotypically Normal Child with Mosaic Trisomy 21.
Won E; Gruber TA; Tucker S; Schiff DE
Case Rep Pediatr; 2020; 2020():7813048. PubMed ID: 32257492
[TBL] [Abstract][Full Text] [Related]
16. Biology and outcome of childhood acute megakaryoblastic leukemia: a single institution's experience.
Athale UH; Razzouk BI; Raimondi SC; Tong X; Behm FG; Head DR; Srivastava DK; Rubnitz JE; Bowman L; Pui CH; Ribeiro RC
Blood; 2001 Jun; 97(12):3727-32. PubMed ID: 11389009
[TBL] [Abstract][Full Text] [Related]
17. Mutations in GATA1 in both transient myeloproliferative disorder and acute megakaryoblastic leukemia of Down syndrome.
Greene ME; Mundschau G; Wechsler J; McDevitt M; Gamis A; Karp J; Gurbuxani S; Arceci R; Crispino JD
Blood Cells Mol Dis; 2003; 31(3):351-6. PubMed ID: 14636651
[TBL] [Abstract][Full Text] [Related]
18. Down syndrome and malignancies: a unique clinical relationship: a paper from the 2008 william beaumont hospital symposium on molecular pathology.
Xavier AC; Ge Y; Taub JW
J Mol Diagn; 2009 Sep; 11(5):371-80. PubMed ID: 19710397
[TBL] [Abstract][Full Text] [Related]
19. Improved outcome of pediatric patients with acute megakaryoblastic leukemia in the AML-BFM 04 trial.
Schweitzer J; Zimmermann M; Rasche M; von Neuhoff C; Creutzig U; Dworzak M; Reinhardt D; Klusmann JH
Ann Hematol; 2015 Aug; 94(8):1327-36. PubMed ID: 25913479
[TBL] [Abstract][Full Text] [Related]
20. Clinical Characteristics and Prognosis of 27 Patients with Childhood Acute Megakaryoblastic Leukemia.
Qi H; Mao Y; Cao Q; Sun X; Kuai W; Song J; Ma L; Hong Z; Hu J; Zhou G
Med Sci Monit; 2020 Jun; 26():e922662. PubMed ID: 32532951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]